Andros Pharmaceuticals Co.,Ltd (6917.TWO)

TWD 15.15

(1.34%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 805 Thousand 1.71 Million 13.31 Million 3.26 Million -
Cost of Revenue 492 Thousand 747 Thousand 4.71 Million 892 Thousand -
Gross Profit 313 Thousand 966 Thousand 8.59 Million 2.37 Million -
Operating Expenses 74.02 Million 47.72 Million 43.5 Million 44.81 Million -60.5 Million
Selling, General and Administrative Expenses 17.16 Million 12.15 Million 10.96 Million 8.5 Million -
Research and Development Expenses 56.86 Million 35.57 Million 32.53 Million 36.31 Million -
Other Expenses 1.64 Million 4.71 Million -2.11 Million 6.13 Million -60.5 Million
Cost and Expenses 74.51 Million 48.47 Million 48.21 Million 45.7 Million -60.5 Million
Operating Income -67.69 Million -40.71 Million -36.6 Million -42.44 Million -60.5 Million
Interest Expense 440 Thousand 464 Thousand 500 Thousand 559 Thousand 541 Thousand
Income Tax Expense 22 Thousand 1000.00 25 Thousand 28 Thousand -
Earnings before Tax -68.13 Million -41.17 Million -37.1 Million -35.85 Million -
Net Income -68.15 Million -41.17 Million -37.13 Million -35.88 Million -
Earnings Per Share Basic -1.87 -1.25 -1.37 -1.33 -2.18
Earnings Per Share Diluted -1.87 -1.25 -1.37 -1.33 -2.18
Weighted Average Shares Outstanding 36.44 Million 33.02 Million 27.14 Million 26.93 Million 26.54 Million
Weighted Average Shares Outstanding (Diluted) 36.44 Million 33.02 Million 27.14 Million 26.93 Million -
Gross Margin 0.39 0.56 0.65 0.73 -
EBIT Margin -76.40 -20.05 -2.23 -8.52 -
Profit Margin -84.67 -24.04 -2.79 -10.98 -
EBITDA -61.5 Million -34.34 Million -29.73 Million -27.84 Million -60.5 Million
Earnings Before Tax Margin -84.10 -23.77 -2.75 -12.99 -

Income Statement Charts